A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

As few as one in ten people survive pancreatic cancer five years after their diagnosis — making it the most ...

Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. In Ireland, there are ...

Pancreatic cancer remains one of the most challenging cancers to treat, but research like this could provide a much-needed ...

Cancer patients and others with debilitating conditions have highlighted shortages of a vital drug they say have had a ...

Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development. Scientific Reports , 2025; 15 (1) DOI: 10.1038/s41598-024-83742-4 ...

Local MP Dave Doogan has met with pancreatic cancer survivors to hear the impact of continuing shortages of pancreatic enzyme ...

Because cystic fluid can leak into the bloodstream, Maher's team has studied expansive pancreatic cancer datasets to identify 10 different protein and microRNA biomarkers. Together, these would ...

More information: Laura E. Kane et al, Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development, Scientific Reports (2025 ...

The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing PC at an earlier stage. Pancreatic cancer (PC) is the worst prognosis ...